BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9183654)

  • 1. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.
    Souza RF; Garrigue-Antar L; Lei J; Yin J; Appel R; Vellucci VF; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Reiss M; Meltzer SJ
    Hum Cell; 1996 Sep; 9(3):229-36. PubMed ID: 9183654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms.
    Souza RF; Lei J; Yin J; Appel R; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Meltzer SJ
    Gastroenterology; 1997 Jan; 112(1):40-5. PubMed ID: 8978341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population.
    Chung YJ; Song JM; Lee JY; Jung YT; Seo EJ; Choi SW; Rhyu MG
    Cancer Res; 1996 Oct; 56(20):4662-5. PubMed ID: 8840981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese.
    Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC
    Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Damage to the transforming growth factor TGF-beta type II receptor gene and microsatellite instability in carcinoma cells of the gastrointestinal tract].
    Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Kovalev VK; Vasil'ev SV; Pozharisskiī KM; Lantsov VA
    Vopr Onkol; 1998; 44(6):667-71. PubMed ID: 10087960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
    Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
    Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability.
    Togo G; Toda N; Kanai F; Kato N; Shiratori Y; Kishi K; Imazeki F; Makuuchi M; Omata M
    Cancer Res; 1996 Dec; 56(24):5620-3. PubMed ID: 8971166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
    Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
    Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue.
    Enomoto A; Esumi M; Yamashita K; Takagi K; Takano S; Iwai S
    J Pathol; 2001 Oct; 195(3):349-54. PubMed ID: 11673833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct relationship between polypoid growth type and sporadic colorectal carcinomas with microsatellite instability.
    Komura K; Masuda H; Esumi M
    Hepatogastroenterology; 2001; 48(39):706-10. PubMed ID: 11462908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
    Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
    Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
    Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients.
    Saeki A; Tamura S; Ito N; Kiso S; Matsuda Y; Yabuuchi I; Kawata S; Matsuzawa Y
    Cancer; 2000 Mar; 88(5):1025-9. PubMed ID: 10699890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum.
    Ouyang H; Shiwaku HO; Hagiwara H; Miura K; Abe T; Kato Y; Ohtani H; Shiiba K; Souza RF; Meltzer SJ; Horii A
    Cancer Res; 1997 May; 57(10):1851-4. PubMed ID: 9157973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
    Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.
    Garrigue-Antar L; Souza RF; Vellucci VF; Meltzer SJ; Reiss M
    Lab Invest; 1996 Aug; 75(2):263-72. PubMed ID: 8765326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.
    Myeroff LL; Parsons R; Kim SJ; Hedrick L; Cho KR; Orth K; Mathis M; Kinzler KW; Lutterbaugh J; Park K
    Cancer Res; 1995 Dec; 55(23):5545-7. PubMed ID: 7585631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.